Novel HSD17B13 Inhibitors for Treating Liver Diseases.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel HSD17B13 inhibitors, pharmaceutical compositions, use of such compounds in treating liver diseases, and processes for preparing such compounds.
Keyphrases